Rapid Dose Therapeutics Wants To Buy Consolidated Craft Brands

Life science company Rapid Dose Therapeutics Corp. DOSE agreed to buy Consolidated Craft Brands, a packaged goods company focused on cannabis edibles and related products, for CA$5 million (US$4 million).

Under the proposed deal, Rapid Dose Therapeutics should issue 16.67 million common share units, with each unit comprising of 1 share and 1 share purchase warrant at a price of 30 cents per unit in exchange for all Consolidated Craft Brands’ shares.

Each warrant provides the holder with the right to buy one share of the company for 45 cents per share in the following two years upon finalizing the transaction.

The definitive agreement is projected to close before Feb. 15. 

After the transaction is completed Consolidated Craft Brands will become a wholly-owned subsidiary of Rapid Dose Therapeutics, which will with this acquisition broaden its current operating model of creating, producing, and distributing its products.

Furthermore, Consolidated Craft Brands will bring to Rapid Dose Therapeutics its CPG and Pharma manufacturing proficiency, and a Health Canada Cannabis R&D license with created proprietary formulations.

“I am delighted with this acquisition — it brings significant benefits to our company,” Rapid Dose CEO Mark Upsdell said.

He cited several core assets the company will attain from this acquisition, including the total cash of Consolidated Craft Brands of $3 million, and proceeds of about $900,000; the expertise and assets.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisM&ANewsMarketscannabis industrycannabis salesConsolidated Craft Brandslegal marijuanamarijuanamarijuana stocksRapid Those Therapeutics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.